FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Torrent Pharma Losartan Potassium /Hydrochlorothiazide Recall

Losartan Potassium /Hydrochlorothiazide Tablets, USP 50mg/12

Torrent Pharma Inc. · Basking Ridge, NJ

Risk level
Class II
Reported by FDA
Oct 9, 2019
Recall ID
D-0123-2020
Check your lot numberHow we source this data

Summary

Torrent Pharma recalled Losartan Potassium /Hydrochlorothiazide starting Sep 19, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0123-2020 on Oct 9, 2019. Reason: CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 9.82 parts per million. Status: Ongoing.

Why it was recalled

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 9.82 parts per million.

Product description

Losartan Potassium /Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 90 tablets per bottle, Rx Only, Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920. NDC: 13668-116-90

Lot numbers, UPCs & expiration codes

Lot BEF7D051

Where it was sold

Nationwide USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0123-2020
Classification
Class II
Status
Ongoing
Recall initiated
Sep 19, 2019
FDA report date
Oct 9, 2019
Quantity
17,088 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Torrent Pharma Inc.

Original FDA data

Every field from FDA enforcement report D-0123-2020, exactly as published.

Show all FDA fields
City
Basking Ridge
State
NJ
Status
Ongoing
Country
United States
Event ID
83840
Address
150 Allen Rd Ste 102
Code information
Lot BEF7D051
Postal code
07920-3856
Report date
Oct 9, 2019
Product type
Drugs
Recall number
D-0123-2020
Classification
Class II
Recalling firm
Torrent Pharma Inc.
Product quantity
17,088 bottles
Reason for recall
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 9.82 parts per million.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Losartan Potassium /Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 90 tablets per bottle, Rx Only, Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920. NDC: 13668-116-90
Distribution pattern
Nationwide USA and Puerto Rico
Recall initiation date
Sep 19, 2019
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Oct 2, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0123-2020, published Oct 9, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls